Your browser doesn't support javascript.
loading
Renal Extramedullary Hematopoiesis in Mast Cell Leukemia with Bone Marrow Fibrosis.
Rieke, Damian T; Schmalbrock, Laura K; Ihlow, Jana; Kleo, Karsten; von Brünneck, Ann-Christin; Nolte, Florian; Keller, Ulrich; Ochsenreither, Sebastian.
Afiliação
  • Rieke DT; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Hindenburgdamm 30, Berlin 12203, Germany.
  • Schmalbrock LK; Berlin Institute of Health (BIH) at Charité, Universitätsmedizin Berlin, Anna-Louisa-Karsch-Straße 2, Berlin 10178, Germany.
  • Ihlow J; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kleo K; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Hindenburgdamm 30, Berlin 12203, Germany.
  • von Brünneck AC; Berlin Institute of Health (BIH) at Charité, Universitätsmedizin Berlin, Anna-Louisa-Karsch-Straße 2, Berlin 10178, Germany.
  • Nolte F; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Keller U; Berlin Institute of Health (BIH) at Charité, Universitätsmedizin Berlin, Anna-Louisa-Karsch-Straße 2, Berlin 10178, Germany.
  • Ochsenreither S; Institute of Pathology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117, Germany.
Case Rep Hematol ; 2024: 3502887, 2024.
Article em En | MEDLINE | ID: mdl-38213502
ABSTRACT
Systemic mastocytosis is defined by the clonal proliferation of abnormal mast cells. The clinical course can range from indolent forms with normal life expectancy to advanced mast cell leukemia with dismal prognosis. An association with other diseases, including myeloproliferative neoplasia, has been described. We present a case of a 75-year patient with a history of cutaneous mastocytosis who was diagnosed with mast cell leukemia more than 9 years ago and did not receive treatment. The patient presented to our clinic with acute kidney failure because of renal extramedullary hematopoiesis. Bone marrow histopathology revealed extensive fibrosis and 50% infiltration by mast cells with a c-KIT D816V mutation. No mutations supporting primary myelofibrosis were identified. Treatment with midostaurin was started, and the patient was discharged after improvement of renal function. Here, we discuss diagnostic challenges between different forms of mast cell leukemia and overlaps with other hematological malignancies.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Case Rep Hematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Case Rep Hematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha